Dr Abdou discusses how characteristics of patients with breast cancer impact ADC treatment selection and highlights some of the topline takeaways from breast cancer treatment to come out of the 2023 ASCO Annual Meeting.
Welcome to OncLive On Air®! I’m your host today, Ryan Scott.
OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, sponsored by AstraZeneca, we had the pleasure of speaking with Yara Abdou, MD, on how patient characteristics may affect treatment selection in the second line and beyond in breast cancer and the factors that influence the decision between fam-trastuzumab deruxtecan-nxki (Enhertu; T-DXd) and ado-trastuzumab emtansine (Kadcyla; T-DM1) for patients with HER2-positive disease. Dr Abdou is an assistant professor of medicine in the Department of Medicine, Division of Oncology, at the University of North Carolina School of Medicine in Chapel Hill.
In our exclusive interview, Abdou discussed how patient characteristics impact treatment selection and highlighted some of the topline takeaways from breast cancer treatment to come out of the 2023 ASCO Annual Meeting.
That’s all we have for today! Thank you for listening to this episode of OncLive On Air, sponsored by AstraZeneca. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.
For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.
OncLive is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.
If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!
Thanks again for listening to OncLive On Air.
*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.